2018-03-15

       2018年3月15日上午，諾康達(dá)總經(jīng)理陶秀梅女士，副總經(jīng)理尚麗霞女士，制劑總監(jiān)王卓先生會(huì)見(jiàn)了蒙古國(guó)最大的醫(yī)藥集團(tuán)Monos Pharma LLC的Enkhzaya Bayaraa女士、Tula女士、國(guó)藥集團(tuán)王增繪先生洽談多個(gè)仿制藥品種研發(fā)及工藝技術(shù)輸出合作。
       On the morning of March 15^th 2018, Ms. Tao Xiumei, the General Manager of Nuokangda, Ms. Shang Lixia, the Vice General Manager, and Mr. Wang Zhuo, the Formulation Director, met with Ms. Enkhzaya Bayaraa, the factory director of Monos Pharma LLC, which is the largest  pharmaceutical company in Mongolia. Both parties have already reached cooperation intention of a series of generic drug R&D technology output.

          總經(jīng)理陶秀梅對(duì)Zaya女士一行到訪諾康達(dá)表示熱烈歡迎，向客人詳細(xì)介紹了諾康達(dá)的發(fā)展歷程、業(yè)務(wù)模式、人員團(tuán)隊(duì)、高質(zhì)量的硬件設(shè)施保障體系和國(guó)際合作優(yōu)勢(shì)等。Zaya女士介紹了蒙古醫(yī)療和醫(yī)藥衛(wèi)生現(xiàn)狀，藥品開(kāi)發(fā)的一般流程，及Monos藥廠生產(chǎn)線特點(diǎn)。陶總帶領(lǐng)參觀了諾康達(dá)的實(shí)驗(yàn)室以及移動(dòng)式整粒機(jī)、搖擺制粒機(jī)、濕法制粒機(jī)、氣流粉碎機(jī)、濕法混合制粒機(jī)、高效包衣機(jī)、高剪切乳化分散機(jī)、膠囊灌裝機(jī)等儀器設(shè)備，Zaya女士對(duì)于諾康達(dá)的先進(jìn)的硬件設(shè)施和高效的研發(fā)團(tuán)隊(duì)表示由衷的贊許和驚嘆，期待雙方合作后，諾康達(dá)能作為輸出品種的技術(shù)培訓(xùn)基地，同時(shí)為‘一帶一路’沿線國(guó)家培養(yǎng)醫(yī)藥研發(fā)的高技能人才。諾康達(dá)期待與Monos未來(lái)能將有著悠久歷史的蒙藥方劑進(jìn)行現(xiàn)代化的開(kāi)發(fā)，開(kāi)發(fā)出符合蒙古人民用藥習(xí)慣的、療效好的藥品。并且逐步將特殊醫(yī)用營(yíng)養(yǎng)以及醫(yī)療器械等多種儲(chǔ)備項(xiàng)目全面向蒙古國(guó)進(jìn)行技術(shù)推廣和轉(zhuǎn)移。
       Ms.Tao Xiumei, warmly welcomed Ms. Zaya and her delegations to Nuokangda. Nuokangda’s fast development history, the business model, the team, the high-quality hardware facilities as well as the international cooperation advantages were introduced to the guests. Subsequently, Ms. Zaya introduced the medical and health conditions of Mongolia, the drug R&D process, and the production line of Monos Pharma. Then, Ms. Tao led the guests to the lab visiting the HPLC, swing granulator, the wet mixing granulator, the efficient coating machine, and high-shear emulsifying disperser, etc. Ms.Zaya showed her heartfelt praise and surprise to Nuokangda's highly advanced hardware facilities, and hope that Nuokangda can serve as a tech exporting training base for Monos Pharma after cooperation, and can train more talents in the pharmaceutical science field for countries along the “Belt and Road”. Nuokangda expects to modernize the traditional Mongolian medicine prescriptions with Monos Pharma in the future, and the developed drug will meet the habits and requirement of Mongolian people. In the future, besides the generic drug, special medical use nutrition and medical devices will gradually transfer to Mongolia.



       
          風(fēng)起揚(yáng)帆正當(dāng)時(shí)，四海同心逐新夢(mèng)。作為人類(lèi)建設(shè)命運(yùn)共同體和平發(fā)展的創(chuàng)新之舉，“一帶一路”建設(shè)成效顯著。諾康達(dá)深入學(xué)習(xí)“一帶一路”的國(guó)家戰(zhàn)略思想，高度踐行“一帶一路”的國(guó)家戰(zhàn)略。正是得益于國(guó)家的繁榮富強(qiáng)，高速成長(zhǎng)的諾康達(dá)才能有幸參與到“一帶一路”的具體項(xiàng)目的實(shí)施過(guò)程。諾康達(dá)此次與蒙古國(guó)開(kāi)展的合作項(xiàng)目，作為醫(yī)藥研發(fā)領(lǐng)域的“一帶一路”領(lǐng)域的先行先試，必將會(huì)引領(lǐng)越來(lái)越多的醫(yī)藥研發(fā)以及生產(chǎn)企業(yè)更多地參與到國(guó)家“一帶一路”的偉大事業(yè)！共同鑄就團(tuán)結(jié)，發(fā)展，文明，繁榮的希望之夢(mèng)！
      When the winds sailed, the world is moving toward a goal. As an innovative move in the development of human destiny and peaceful, “the Belt and Road” has achieved remarkable achievement. Nuokangda has thoroughly studied and then highly practiced the national strategy of “the Belt and Road ”. Thanks to the prosperity and prosperity of the country, Nuokandga has the privilege of participating in the business cooperation with Mongolia this time. The cooperation between Nuokangda and Monos Pharma, as a pioneer to implement“the Belt and Road ”strategy in the pharmaceutical science field, is very meaningful and will surely lead more and more pharmaceutical companies to participate in for the great cause of the country. Let us strive to create a unity, development, civilization, and prosperity society!